LEADER 04282nam 2200745 a 450 001 9910829168903321 005 20240516064703.0 010 $a9786613693754 010 $a9781280783364 010 $a1280783362 010 $a9780470720011 010 $a0470720018 010 $a9780470717684 010 $a0470717688 035 $a(CKB)1000000000688064 035 $a(EBL)703843 035 $a(OCoLC)797918286 035 $a(SSID)ssj0000715066 035 $a(PQKBManifestationID)11454815 035 $a(PQKBTitleCode)TC0000715066 035 $a(PQKBWorkID)10700943 035 $a(PQKB)10034091 035 $a(MiAaPQ)EBC703843 035 $a(Au-PeEL)EBL703843 035 $a(CaPaEBR)ebr10575485 035 $a(CaONFJC)MIL369375 035 $a(Perlego)2769820 035 $a(EXLCZ)991000000000688064 100 $a20740422d1973 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 10$aImmunopotentiation 205 $a1st ed. 210 $aAmsterdam $cElsevier$d1973 215 $a1 online resource (368 pages) 225 1 $aCiba Foundation symposium (new series) ;$v18 300 $a"Symposium on Immunopotentiation, held at the Ciba Foundation, London, 18th-19th January 1973"--Participants page. 311 0 $a9780470663110 311 0 $a0470663111 311 0 $a9789021940199 311 0 $a9021940191 320 $aIncludes bibliographical references and indexes. 327 $aImmunopotentiation; Contents; Introduction; The cellular targets for the action of adjuvants : T-adjuvants and B-adjuvants; Discussion; The relation of lymphocyte trapping to the mode of action of adjuvants; Discussion; Immunopotentiation by mycobacteria in complete Freund-type adjuvant as the failure of normal immunological homeostasis; Discussion; Effects of adjuvants on different cell types and their interactions in immune responses; Discussion; Cellular mechanisms underlying the adjuvant activity of Corynebacterium parvurn: interactions of activated macrophages with T and B lymphocytes 327 $aDiscussionChemotaxis of macrophages : the role of a macrophage-specific cytotaxin from anaerobic corynebacteria and its relation to immunopotentiation in vivo; Discussion; The allogeneic effect on the immune system and its potential applications to tumour immunity; Discussion; Mitogens as probes for immunocyte activ- ation : specific and non-specific paralysis of B cell mitogenesis; Discussion; General Discussion I The T cell-deprived mouse; The use of viruses as immunological potentiators; Discussion 327 $aCorynebacterium parvum, a potent immunostimu-lant in experimental infections and in malignanciesDiscussion; Orchidectomy as a method of immunopotentiation in mice; Discussion; The nature of immunopotentiation by the anti-tumour polysaccharide lentinan and the significance of biogenic amines in its action; Discussion; The effect of Corynebacterium parvum and other reticuloendothelial stimulants on transplanted tumours in mice; Discussion; Attempt at using systemic immunity adjuvants in experimental and human cancer therapy; Discussion 327 $aGeneral Discussion II Restoration of immune capability in cancer patientsSites of action of adjuvants; Conclusion; Index of contributors; Subject index 330 8 $aThe Novartis Foundation Series is a popular collection of the proceedings from Novartis Foundation Symposia, in which groups of leading scientists from a range of topics across biology, chemistry and medicine assembled to present papers and discuss results. The Novartis Foundation, originally known as the Ciba Foundation, is well known to scientists and clinicians around the world. 410 0$aCiba Foundation symposium ;$vnew ser. 18. 606 $aImmunological adjuvants$vCongresses 606 $aTumors$xImmunological aspects$vCongresses 615 0$aImmunological adjuvants 615 0$aTumors$xImmunological aspects 676 $a574.2/9 712 02$aCiba Foundation. 712 12$aSymposium on Immunopotentiation 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910829168903321 996 $aImmunopotentiation$92190300 997 $aUNINA